Literature DB >> 31800366

Natural Killer Cell Regulation of B Cell Responses in the Context of Viral Infection.

Ivayla E Gyurova1,2, Ayad Ali1,3,4, Stephen N Waggoner1,2,3,4,5.   

Abstract

Secretion of both neutralizing and nonneutralizing virus-specific antibodies by B cells is a key component of immune control of many virus infections and a critical benchmark of successful preventative vaccines. Natural killer (NK) cells also play a vital role in antiviral immune defense via cytolytic elimination of infected cells and production of proinflammatory antiviral cytokines. Accumulating evidence points to multifaceted crosstalk between NK cells and antiviral B cell responses that can determine virus elimination, pathogenesis of infection, and efficacy of vaccine-elicited protection. These outcomes are a result of both positive and negative influences of NK cells on the B cell responses, as well as canonical antiviral killing of infected B cells. On one hand, NK cell-derived cytokines such as interferon-gamma (IFN-γ) may promote B cell activation and enhance immunoglobulin production. In contrast, NK cell immunoregulatory killing of CD4 T cells can limit affinity maturation in germinal centers resulting in weak infection or vaccine induction of antiviral neutralizing antibodies. In this review, we will discuss these and other dueling contributions of NK cells to B cell responses during virus infection or vaccination.

Entities:  

Keywords:  IFN-γ; NK; humoral; immunoglobulin; perforin; virus

Mesh:

Substances:

Year:  2019        PMID: 31800366      PMCID: PMC7247022          DOI: 10.1089/vim.2019.0129

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  126 in total

1.  The rapid induction of HLA-E is essential for the survival of antigen-activated naive CD4 T cells from attack by NK cells.

Authors:  Sumiko Takao; Takayuki Ishikawa; Kouhei Yamashita; Takashi Uchiyama
Journal:  J Immunol       Date:  2010-10-15       Impact factor: 5.422

Review 2.  Natural killer cell memory in infection, inflammation and cancer.

Authors:  Adelheid Cerwenka; Lewis L Lanier
Journal:  Nat Rev Immunol       Date:  2016-01-25       Impact factor: 53.106

Review 3.  Up on the tightrope: natural killer cell activation and inhibition.

Authors:  Lewis L Lanier
Journal:  Nat Immunol       Date:  2008-05       Impact factor: 25.606

4.  Large granular lymphocytes inhibit the in vitro growth of autologous Epstein-Barr virus-infected B cells.

Authors:  M G Masucci; M T Bejarano; G Masucci; E Klein
Journal:  Cell Immunol       Date:  1983-03       Impact factor: 4.868

5.  Homeostasis of the antibody response: immunoregulation by NK cells.

Authors:  L V Abruzzo; D A Rowley
Journal:  Science       Date:  1983-11-11       Impact factor: 47.728

Review 6.  The widening spectrum of immunological memory.

Authors:  Colleen M Lau; Joseph C Sun
Journal:  Curr Opin Immunol       Date:  2018-06-11       Impact factor: 7.486

7.  Natural Killer-like B Cells Prime Innate Lymphocytes against Microbial Infection.

Authors:  Shuo Wang; Pengyan Xia; Yi Chen; Guanling Huang; Zhen Xiong; Jing Liu; Chong Li; Buqing Ye; Ying Du; Zusen Fan
Journal:  Immunity       Date:  2016-07-12       Impact factor: 31.745

8.  Natural killer cells act as rheostats modulating antiviral T cells.

Authors:  Stephen N Waggoner; Markus Cornberg; Liisa K Selin; Raymond M Welsh
Journal:  Nature       Date:  2011-11-20       Impact factor: 49.962

Review 9.  Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer.

Authors:  Rohtesh S Mehta; Katayoun Rezvani
Journal:  Front Immunol       Date:  2018-02-15       Impact factor: 7.561

10.  Elimination in vivo of developing T cells by natural killer cells.

Authors:  Eckart Schott; Roberto Bonasio; Hidde L Ploegh
Journal:  J Exp Med       Date:  2003-10-20       Impact factor: 14.307

View more
  5 in total

Review 1.  Challenges at the Time of COVID-19: Opportunities and Innovations in Antivirals from Nature.

Authors:  Andreas Hensel; Rudolf Bauer; Michael Heinrich; Verena Spiegler; Oliver Kayser; Georg Hempel; Karin Kraft
Journal:  Planta Med       Date:  2020-05-20       Impact factor: 3.352

2.  In quest of a new therapeutic approach in COVID-19: the endocannabinoid system.

Authors:  Ondine Lucaciu; Ovidiu Aghiorghiesei; Nausica Bianca Petrescu; Ioana Codruta Mirica; Horea Rareș Ciprian Benea; Dragoș Apostu
Journal:  Drug Metab Rev       Date:  2021-03-08       Impact factor: 4.518

Review 3.  microRNA, a Subtle Indicator of Human Cytomegalovirus against Host Immune Cells.

Authors:  Mengyao Yu; Yuexinzi Jin; Shichang Zhang; Jian Xu; Jiexin Zhang
Journal:  Vaccines (Basel)       Date:  2022-01-19

Review 4.  NK Cells in Protection from HIV Infection.

Authors:  Nicole F Bernard; Khlood Alsulami; Erik Pavey; Franck P Dupuy
Journal:  Viruses       Date:  2022-05-25       Impact factor: 5.818

5.  Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients.

Authors:  Sabine Haggenburg; Birgit I Lissenberg-Witte; Rob S van Binnendijk; Gerco den Hartog; Michel S Bhoekhan; Nienke J E Haverkate; Dennis M de Rooij; Johan van Meerloo; Jacqueline Cloos; Neeltje A Kootstra; Dorine Wouters; Suzanne S Weijers; Ester M M van Leeuwen; Hetty J Bontkes; Saïda Tonouh-Aajoud; Mirjam H M Heemskerk; Rogier W Sanders; Elianne Roelandse-Koop; Quincy Hofsink; Kazimierz Groen; Lucia Çetinel; Louis Schellekens; Yvonne M den Hartog; Belle Toussaint; Iris M J Kant; Thecla Graas; Emma de Pater; Willem A Dik; Marije D Engel; Cheyenne R N Pierie; Suzanne R Janssen; Edith van Dijkman; Meliawati Poniman; Judith A Burger; Joey H Bouhuijs; Gaby Smits; Nynke Y Rots; Sonja Zweegman; Arnon P Kater; Tom van Meerten; Pim G N J Mutsaers; Jaap A van Doesum; Annoek E C Broers; Marit J van Gils; Abraham Goorhuis; Caroline E Rutten; Mette D Hazenberg; Inger S Nijhof
Journal:  Blood Adv       Date:  2022-03-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.